Automation in Biopharmaceutical Market Report – Research, Industry Analysis Reports and Market Demands

Global Automation in Biopharmaceutical Market Insights, Forecast to 2025

Request for Sample of this report

Buy now

Table of Content

1 Study Coverage

1.1 Automation in Biopharmaceutical Product
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered
1.4 Market by Type
- 1.4.1 Global Automation in Biopharmaceutical Market Size Growth Rate by Type
- 1.4.2 Clinical stage automation
- 1.4.3 Drug discovery stage automation
1.5 Market by Application
- 1.5.1 Global Automation in Biopharmaceutical Market Size Growth Rate by Application
- 1.5.2 Research and Development
- 1.5.3 Clinical
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary

2.1 Global Automation in Biopharmaceutical Market Size
- 2.1.1 Global Automation in Biopharmaceutical Revenue 2014-2025
- 2.1.2 Global Automation in Biopharmaceutical Production 2014-2025
2.2 Automation in Biopharmaceutical Growth Rate (CAGR) 2019-2025
2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Key Automation in Biopharmaceutical Manufacturers
  - 2.3.2.1 Automation in Biopharmaceutical Manufacturing Base Distribution, Headquarters
  - 2.3.2.2 Manufacturers Automation in Biopharmaceutical Product Offered
  - 2.3.2.3 Date of Manufacturers Enter into Automation in Biopharmaceutical Market
2.4 Key Trends for Automation in Biopharmaceutical Markets & Products

3 Market Size by Manufacturers

3.1 Automation in Biopharmaceutical Production by Manufacturers
- 3.1.1 Automation in Biopharmaceutical Production by Manufacturers
- 3.1.2 Automation in Biopharmaceutical Production Market Share by Manufacturers
3.2 Automation in Biopharmaceutical Revenue by Manufacturers
- 3.2.1 Automation in Biopharmaceutical Revenue by Manufacturers (2014-2019)
- 3.2.2 Automation in Biopharmaceutical Revenue Share by Manufacturers (2014-2019)
3.3 Automation in Biopharmaceutical Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans

4 Automation in Biopharmaceutical Production by Regions

4.1 Global Automation in Biopharmaceutical Production by Regions
- 4.1.1 Global Automation in Biopharmaceutical Production Market Share by Regions
- 4.1.2 Global Automation in Biopharmaceutical Revenue Market Share by Regions
4.2 United States
- 4.2.1 United States Automation in Biopharmaceutical Production
- 4.2.2 United States Automation in Biopharmaceutical Revenue
- 4.2.3 Key Players in United States
- 4.2.4 United States Automation in Biopharmaceutical Import & Export
4.3 Europe
- 4.3.1 Europe Automation in Biopharmaceutical Production
- 4.3.2 Europe Automation in Biopharmaceutical Revenue
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Automation in Biopharmaceutical Import & Export
4.4 China
- 4.4.1 China Automation in Biopharmaceutical Production
- 4.4.2 China Automation in Biopharmaceutical Revenue
- 4.4.3 Key Players in China
- 4.4.4 China Automation in Biopharmaceutical Import & Export
4.5 Japan
- 4.5.1 Japan Automation in Biopharmaceutical Production
- 4.5.2 Japan Automation in Biopharmaceutical Revenue
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Automation in Biopharmaceutical Import & Export
4.6 South Korea
- 4.6.1 South Korea Automation in Biopharmaceutical Production
- 4.6.2 South Korea Automation in Biopharmaceutical Revenue
- 4.6.3 Key Players in South Korea
- 4.6.4 South Korea Automation in Biopharmaceutical Import & Export
4.7 India
- 4.7.1 India Automation in Biopharmaceutical Production
- 4.7.2 India Automation in Biopharmaceutical Revenue
- 4.7.3 Key Players in India
- 4.7.4 India Automation in Biopharmaceutical Import & Export
4.8 Other Regions

5 Automation in Biopharmaceutical Consumption by Regions

5.1 Global Automation in Biopharmaceutical Consumption by Regions
- 5.1.1 Global Automation in Biopharmaceutical Consumption by Regions
- 5.1.2 Global Automation in Biopharmaceutical Consumption Market Share by Regions
5.2 North America
- 5.2.1 North America Automation in Biopharmaceutical Consumption by Application
- 5.2.2 North America Automation in Biopharmaceutical Consumption by Countries
- 5.2.3 United States
- 5.2.4 Canada
- 5.2.5 Mexico
5.3 Europe
- 5.3.1 Europe Automation in Biopharmaceutical Consumption by Application
- 5.3.2 Europe Automation in Biopharmaceutical Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 UK
- 5.3.6 Italy
- 5.3.7 Russia
5.4 Asia Pacific
- 5.4.1 Asia Pacific Automation in Biopharmaceutical Consumption by Application
- 5.4.2 Asia Pacific Automation in Biopharmaceutical Consumption by Countries
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Indonesia
- 5.4.9 Thailand
- 5.4.10 Malaysia
- 5.4.11 Philippines
- 5.4.12 Vietnam
5.5 Central & South America
- 5.5.1 Central & South America Automation in Biopharmaceutical Consumption by Application
- 5.5.2 Central & South America Automation in Biopharmaceutical Consumption by Country
- 5.5.3 Brazil
5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Automation in Biopharmaceutical Consumption by Application
- 5.6.2 Middle East and Africa Automation in Biopharmaceutical Consumption by Countries
- 5.6.3 GCC Countries
- 5.6.4 Egypt
- 5.6.5 South Africa

6 Market Size by Type

6.1 Global Automation in Biopharmaceutical Production by Type
6.2 Global Automation in Biopharmaceutical Revenue by Type
6.3 Automation in Biopharmaceutical Price by Type

7 Market Size by Application

7.1 Overview
7.2 Global Automation in Biopharmaceutical Breakdown Dada by Application
- 7.2.1 Global Automation in Biopharmaceutical Consumption by Application
- 7.2.2 Global Automation in Biopharmaceutical Consumption Market Share by Application (2014-2019)

8 Key Industry Players

9 Entry Strategy for Key Countries

9.1 Entry Strategy for United States Market
9.2 Entry Strategy for China Market
9.3 Entry Strategy for India Market

10 Production Forecasts

10.1 Automation in Biopharmaceutical Production and Revenue Forecast
- 10.1.1 Global Automation in Biopharmaceutical Production Forecast 2019-2025
- 10.1.2 Global Automation in Biopharmaceutical Revenue Forecast 2019-2025
10.2 Automation in Biopharmaceutical Production and Revenue Forecast by Regions
- 10.2.1 Global Automation in Biopharmaceutical Revenue Forecast by Regions
- 10.2.2 Global Automation in Biopharmaceutical Production Forecast by Regions
10.3 Automation in Biopharmaceutical Key Producers Forecast
- 10.3.1 United States
- 10.3.2 Europe
- 10.3.3 China
- 10.3.4 Japan
- 10.3.5 South Korea
- 10.3.6 India
10.4 Forecast by Type
- 10.4.1 Global Automation in Biopharmaceutical Production Forecast by Type
- 10.4.2 Global Automation in Biopharmaceutical Revenue Forecast by Type

11 Consumption Forecast

11.1 Automation in Biopharmaceutical Consumption Forecast by Application
11.2 Automation in Biopharmaceutical Consumption Forecast by Regions
11.3 North America Market Consumption Forecast
- 11.3.1 North America Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025
- 11.3.2 United States
- 11.3.3 Canada
- 11.3.4 Mexico
11.4 Europe Market Consumption Forecast
- 11.4.1 Europe Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025
- 11.4.2 Germany
- 11.4.3 France
- 11.4.4 UK
- 11.4.5 Italy
- 11.4.6 Russia
11.5 Asia Pacific Market Consumption Forecast
- 11.5.1 Asia Pacific Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025
- 11.5.2 China
- 11.5.3 Japan
- 11.5.4 South Korea
- 11.5.5 India
- 11.5.6 Australia
- 11.5.7 Indonesia
- 11.5.8 Thailand
- 11.5.9 Malaysia
- 11.5.10 Philippines
- 11.5.11 Vietnam
11.6 Central & South America Market Consumption Forecast
- 11.6.1 Central & South America Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025
- 11.6.2 Brazil
11.7 Middle East and Africa Market Consumption Forecast
- 11.7.1 Middle East and Africa Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025
- 11.7.2 GCC Countries
- 11.7.3 Egypt
- 11.7.4 South Africa

12 Opportunities & Challenges, Threat and Affecting Factors

12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter's Five Forces Analysis

13 Key Findings in the Global Automation in Biopharmaceutical Study

14 Appendix

14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
  - 14.1.1.1 Research Programs/Design
  - 14.1.1.2 Market Size Estimation
  - 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
  - 14.1.2.1 Secondary Sources
  - 14.1.2.2 Primary Sources
14.2 Author Details

Description

The global biopharmaceutical industry is the most rapidly growing industry in the science and technology sector owing to increasing R&D investments in biopharmaceutical drug development facilities. The global automation market in biopharmaceutical industry includes deployment of automation in biopharmaceutical academic research centers, manufacturing and research companies, clinical labs, and government approved labs.
One trend in the market is continuous manufacturing. Advantages of continuous operations are well-recognized in various industries. It completes the process in a shorter time as it omits the hold steps, reduces shut down time, and reduces the labor requirement. Over the decades, upstream processing utilized this technology.”
According to the report, one driver in the market is use of automation in data acquisition. Traditionally, research labs collect data manually and store it in spreadsheets. This method is not only time-consuming but also affects operational efficiency and is prone to errors. It also restricts monitoring of data in real time. The biopharmaceutical industry is working on data collection and adding the information from spreadsheets to a database. Database collection of upstream and downstream processes is being utilized to create a library that increases operational efficiency and process optimization.
Further, the report states that one challenge in the market is high R&D cost. The biopharmaceutical industry is a rapidly growing industry in pharmaceuticals. Complex drugs are manufactured with the help of 3-D modeling and are produced with high efficacy and precision. These drugs can provide medication to medical issues that were once incurable. Currently, the biopharmaceutical industry is looking to yield new products to address diseases such as cancer, Alzheimer's disease, and hepatitis C. Innovations in the biopharmaceutical industry are highly expensive. The average cost associated with a new drug is around $2 billion, including the cost of unsuccessful drug approvals, out of which almost $400 million is the cost included in pre-clinical and clinical testing.
Global Automation in Biopharmaceutical market size will reach 1590 million US$ by 2025, from 1040 million US$ in 2018, at a CAGR of 6.2% during the forecast period. In this study, 2018 has been considered as the base year and 2019-2025 as the forecast period to estimate the market size for Automation in Biopharmaceutical.

This industry study presents the global Automation in Biopharmaceutical market size, historical breakdown data (2014-2019) and forecast (2019-2025). The Automation in Biopharmaceutical production, revenue and market share by manufacturers, key regions and type;
The consumption of Automation in Biopharmaceutical in volume terms are also provided for major countries (or regions), and for each application and product at the global level. Market share, growth rate, and competitive factors are also evaluated for market leaders Danaher, GE, etc.

The following manufacturers are covered in this report:
Danaher
GE
PerkinElmer
Tecan Trading
Thermo Fisher Scientific
Bruker
Peak Analysis & Automation
Waters
Capsugel
RheoSense
Eirechrom
BioProcess International
Novasep

Automation in Biopharmaceutical Breakdown Data by Type
Clinical stage automation
Drug discovery stage automation
Automation in Biopharmaceutical Breakdown Data by Application
Research and Development
Clinical

Automation in Biopharmaceutical Production by Region
United States
Europe
China
Japan
South Korea
India
Other Regions

Automation in Biopharmaceutical Consumption by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa

The study objectives are:
To analyze and research the global Automation in Biopharmaceutical status and future forecast，involving, production, revenue, consumption, historical and forecast.
To present the key Automation in Biopharmaceutical manufacturers, production, revenue, market share, SWOT analysis and development plans in next few years.
To segment the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Automation in Biopharmaceutical :
History Year: 2014 - 2018
Base Year: 2018
Estimated Year: 2019
Forecast Year: 2019 - 2025

This report includes the estimation of market size for value (million USD) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Automation in Biopharmaceutical market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.